Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study

Author： Mas Sergi LLerena Adrián Saíz Jerónimo Bernardo Miquel Lafuente Amalia

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.15, 2012-11, pp. : 1773-1782

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study

By Liu Qian Jamba Maidar Patrick III Calvin Padmanabhan Saranya Brennan Mark D

Pharmacogenomics, Vol. 13, Iss. 11, 2012-08 ,pp. : 1227-1237

Future Medicine

Access to resources Recommend Favorite

Glycine transport inhibitors as potential antipsychotic drugs

By Aubrey Karin R Vandenberg Robert J

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 507-518

Informa Healthcare

Access to resources Recommend Favorite

A pharmaco-EEG study on antipsychotic drugs in healthy volunteers

By Yoshimura Masafumi Koenig Thomas Irisawa Satoshi Isotani Toshiaki Yamada Keizo Kikuchi Mitsuru Okugawa Gaku Yagyu Takami Kinoshita Toshihiko Strik Werner Dierks Thomas

Psychopharmacology, Vol. 191, Iss. 4, 2007-05 ,pp. : 995-1004

Springer Publishing Company

Access to resources Recommend Favorite

Interaction of Antipsychotic Drugs with Sucrase, Kinetics and Structural Study

Current Clinical Pharmacology, Vol. 12, Iss. 1, 2017-06 ,pp. : 50-54

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptor Genes as Candidates for Pharmacogenetic Studies of Current and Future Antipsychotic Agents in Schizophrenia

Current Pharmacogenomics, Vol. 5, Iss. 1, 2007-03 ,pp. : 21-30

Bentham Science Publishers

Access to resources Recommend Favorite